| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |